# FDA Inspection 1264741 - Axogen Corporation - March 06, 2025

Source: https://www.keypedia.com/records/fda_inspections/axogen-corporation/870867bc-ce2b-4a7a-ab11-cbb2f3cb9675
Source feed: FDA_Inspections

> FDA Inspection 1264741 for Axogen Corporation on March 06, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264741
- Company Name: Axogen Corporation
- Inspection Date: 2025-03-06
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1264741 - 2025-03-06](https://www.keypedia.com/records/fda_inspections/axogen-corporation/41786ae4-8699-453e-a6b9-f4008d6d0be4)
- [FDA Inspection 1232568 - 2024-02-29](https://www.keypedia.com/records/fda_inspections/axogen-corporation/61d8eedd-854d-4534-9a2a-75e26d46ef9a)
- [FDA Inspection 1232568 - 2024-02-29](https://www.keypedia.com/records/fda_inspections/axogen-corporation/7ebd41e9-65c7-4c67-831f-9c309e29cd8d)

Company: https://www.keypedia.com/companies/axogen-corporation/68eb0cbb-a9e9-482d-9953-4ddb866a8dc8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d